Computational Redesign of the SHV-1 β-Lactamase/β-Lactamase Inhibitor Protein Interface

被引:39
|
作者
Reynolds, Kimberly A. [1 ,2 ]
Hanes, Melinda S. [1 ,2 ]
Thomson, Jodi M. [3 ,4 ]
Antczak, Andrew J. [5 ]
Berger, James M. [5 ]
Bonomo, Robert A. [3 ,4 ]
Kirsch, Jack F. [5 ]
Handel, Tracy M. [1 ]
机构
[1] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA
[2] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA
[3] Case Western Reserve Univ, Sch Med, Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA
[5] Univ Calif Berkeley, Dept Mol & Cell Biol, Inst QB3, Berkeley, CA 94720 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
SHV-1; beta-lactamase; beta-lactamase inhibitor protein (BLIP); computational protein design; EGAD; protein-protein interactions;
D O I
10.1016/j.jmb.2008.05.051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta-lactamases are enzymes that catalyze the hydrolysis of beta-lactam antibiotics. beta-lactamase/beta-lactamase inhibitor protein (BLIP) complexes are emerging as a well characterized experimental model system for studying protein-protein interactions. BLIP is a 165 amino acid protein that inhibits several class A beta-lactamases with a wide range of affinities: picomolar affinity for K1; nanomolar affinity for TEM-1, SME-1, and BlaI; but only micromolar affinity for SHV-1 beta-lactamase. The large differences in affinity coupled with the availability of extensive mutagenesis data and high-resolution crystal structures for the TEM-1/BLIP and SHV-1/BLIP complexes make them attractive systems for the further development of computational design methodology. We used EGAD, a physics-based computational design program, to redesign BLIP in an attempt to increase affinity for SHV-1. Characterization of several of designs and point mutants revealed that in all cases, the mutations stabilize the interface by 10- to 1000-fold relative to wild type BLIP. The calculated changes in binding affinity for the mutants were within a mean absolute error of 0.87 kcal/mol from the experimental values, and comparison of the calculated and experimental values for a set of 30 SHV-1/BLIP complexes yielded a correlation coefficient of 0.77. Structures of the two complexes with the highest affinity, SHV-1/BLIP (E73M) and SHV-1/BLIP (E73M, S130K, S146M), are presented at 1.7 angstrom resolution. While the predicted structures have much in common with the experimentally determined structures, they do not coincide perfectly; in particular a salt bridge between SHV-1 D104 and BLIP K74 is observed in the experimental structures, but not in the predicted design conformations. This discrepancy highlights the difficulty of modeling salt bridge interactions with a protein design algorithm that approximates side chains as discrete rotamers. Nevertheless, while local structural features of the interface were sometimes miscalculated, EGAD is globally successful in designing complexes with increased affinity. (C) 2008 Published by Elsevier Ltd.
引用
收藏
页码:1265 / 1275
页数:11
相关论文
共 50 条
  • [1] Structural and computational characterization of the SHV-1 β-lactamase-β- lactamase inhibitor protein interface
    Reynolds, Kimberly A.
    Thomson, Jodi M.
    Corbett, Kevin D.
    Bethel, Christopher R.
    Berger, James M.
    Kirsch, Jack F.
    Bonomo, Robert A.
    Handel, Tracy M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (36) : 26745 - 26753
  • [2] Structure of the SHV-1 β-lactamase
    Kuzin, AP
    Nukaga, M
    Nukaga, Y
    Hujer, AM
    Bonomo, RA
    Knox, JR
    BIOCHEMISTRY, 1999, 38 (18) : 5720 - 5727
  • [3] STRUCTURE OF SHV-1 β-LACTAMASE AND ITS COMPLEX WITH TAZOBACTAM
    Knox, J. R.
    Kuzin, A. P.
    Nukaga, M.
    Nukaga, Y.
    Hujer, A. M.
    Bonomo, R. A.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1999, 55 : 152 - 152
  • [4] NATURE OF THE GENETIC DETERMINANT FOR THE SHV-1 BETA-LACTAMASE
    NUGENT, ME
    HEDGES, RW
    MOLECULAR AND GENERAL GENETICS, 1979, 175 (03): : 239 - 243
  • [5] Tazobactam inactivation of SHV-1 and the inhibitor-resistant Ser130→Gly SHV-1 β-lactamase -: Insights into the mechanism of inhibition
    Pagan-Rodriguez, D
    Zhou, X
    Simmons, R
    Bethel, CR
    Hujer, AM
    Helfand, MS
    Jin, ZY
    Guo, BC
    Anderson, VE
    Ng, LM
    Bonomo, RA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (19) : 19494 - 19501
  • [6] Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 β-lactamase -: Insights into the mechanism of inhibition
    Sulton, D
    Pagan-Rodriguez, D
    Zhou, X
    Liu, YD
    Hujer, AM
    Bethel, CR
    Helfand, MS
    Thomson, JM
    Anderson, VE
    Buynak, JD
    Ng, LM
    Bonomo, RA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (42) : 35528 - 35536
  • [7] MOLECULAR-CLONING OF THE SHV-1 BETA-LACTAMASE GENE AND CONSTRUCTION OF AN SHV-1 HYBRIDIZATION PROBE
    BISESSAR, U
    JAMES, R
    JOURNAL OF GENERAL MICROBIOLOGY, 1988, 134 : 835 - 840
  • [8] Computational redesign of protein-protein interactions:: Stabilizing β-lactamase/inhibitor complexes
    Reynolds, K
    Handel, T
    BIOPHYSICAL JOURNAL, 2005, 88 (01) : 333A - 333A
  • [9] OHIO-1 BETA-LACTAMASE IS PART OF THE SHV-1 FAMILY
    SHLAES, DM
    CURRIEMCCUMBER, C
    HULL, A
    BEHLAU, I
    KRON, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (08) : 1570 - 1576
  • [10] Inhibition of the SHV-1 β-lactamase by sulfones:: Crystallographic observation of two reaction intermediates with tazobactam
    Kuzin, AP
    Nukaga, M
    Nukaga, Y
    Hujer, A
    Bonomo, RA
    Knox, JR
    BIOCHEMISTRY, 2001, 40 (06) : 1861 - 1866